InvestorsHub Logo
Followers 97
Posts 128742
Boards Moderated 1
Alias Born 07/24/2016

Re: None

Monday, 02/06/2017 10:58:10 AM

Monday, February 06, 2017 10:58:10 AM

Post# of 197518

$ENTB Entest BioMedical Inc.'s Subsidiary Zander Therapeutics Makes Key Additions to Management Team as the Company Prepares to Move Forward in the $63 Billion Veterinary / Pet Market Niche

http://finance.yahoo.com/news/entest-biomedical-inc-subsidiary-zander-133000390.html;_ylt=A0LEViopmphYLMUAkdUnnIlQ;_ylu=X3oDMTByMjB0aG5zBGNvbG8DYmYxBHBvcwMxBHZ0aWQDBHNlYwNzYw--

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.